$SDGR
Schrodinger, Inc.

2024 Q3 Form 10-Q Financial Statement

#000149097824000089 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $35.29M
YoY Change -17.1%
Cost Of Revenue $17.56M
YoY Change -7.23%
Gross Profit $17.73M
YoY Change -25.01%
Gross Profit Margin 50.24%
Selling, General & Admin $35.17M
YoY Change 6.59%
% of Gross Profit 198.4%
Research & Development $50.98M
YoY Change 8.85%
% of Gross Profit 287.55%
Depreciation & Amortization $1.558M
YoY Change 22.68%
% of Gross Profit 8.79%
Operating Expenses $86.15M
YoY Change 7.91%
Operating Profit -$68.42M
YoY Change 21.76%
Interest Expense $30.20M
YoY Change -446.28%
% of Operating Profit
Other Income/Expense, Net $30.20M
YoY Change -446.36%
Pretax Income -$38.23M
YoY Change -41.11%
Income Tax -$90.00K
% Of Pretax Income
Net Earnings -$38.14M
YoY Change -38.51%
Net Earnings / Revenue -108.06%
Basic Earnings Per Share -$0.52
Diluted Earnings Per Share -$0.52
COMMON SHARES
Basic Shares Outstanding 72.81M shares
Diluted Shares Outstanding 72.81M shares

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $388.7M
YoY Change -21.68%
Cash & Equivalents $160.4M
Short-Term Investments $228.3M
Other Short-Term Assets $22.90M
YoY Change 18.63%
Inventory
Prepaid Expenses $13.14M
Receivables $13.28M
Other Receivables $1.014M
Total Short-Term Assets $456.4M
YoY Change -16.68%
LONG-TERM ASSETS
Property, Plant & Equipment $137.7M
YoY Change 512.22%
Goodwill $4.791M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $65.22M
YoY Change -29.01%
Other Assets $5.153M
YoY Change -30.49%
Total Long-Term Assets $212.9M
YoY Change -13.59%
TOTAL ASSETS
Total Short-Term Assets $456.4M
Total Long-Term Assets $212.9M
Total Assets $669.3M
YoY Change -15.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.21M
YoY Change 8.65%
Accrued Expenses $58.13M
YoY Change 15.57%
Deferred Revenue $41.77M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $111.1M
YoY Change 5.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $297.0K
YoY Change -57.99%
Total Long-Term Liabilities $297.0K
YoY Change -57.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $111.1M
Total Long-Term Liabilities $297.0K
Total Liabilities $219.9M
YoY Change -4.64%
SHAREHOLDERS EQUITY
Retained Earnings -$485.3M
YoY Change 57.7%
Common Stock $933.4M
YoY Change 7.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $449.4M
YoY Change
Total Liabilities & Shareholders Equity $669.3M
YoY Change -15.72%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$38.14M
YoY Change -38.51%
Depreciation, Depletion And Amortization $1.558M
YoY Change 22.68%
Cash From Operating Activities -$33.26M
YoY Change -33.41%
INVESTING ACTIVITIES
Capital Expenditures $1.342M
YoY Change -72.67%
Acquisitions
YoY Change
Other Investing Activities $92.05M
YoY Change 407.98%
Cash From Investing Activities $90.70M
YoY Change 587.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 392.0K
YoY Change -70.53%
NET CHANGE
Cash From Operating Activities -33.26M
Cash From Investing Activities 90.70M
Cash From Financing Activities 392.0K
Net Change In Cash 57.84M
YoY Change -263.34%
FREE CASH FLOW
Cash From Operating Activities -$33.26M
Capital Expenditures $1.342M
Free Cash Flow -$34.60M
YoY Change -36.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
SDGR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
160416000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155315000 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
9760000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
5751000 usd
CY2024Q3 sdgr Unbilled And Other Receivables Current
UnbilledAndOtherReceivablesCurrent
31542000 usd
CY2023Q4 sdgr Unbilled And Other Receivables Current
UnbilledAndOtherReceivablesCurrent
23124000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13136000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9926000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
456398000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
567796000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
65216000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
83251000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
4791000 usd
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Schrodinger, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4284541
dei Entity Address Address Line1
EntityAddressAddressLine1
1540 Broadway
dei Entity Address Address Line2
EntityAddressAddressLine2
24th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
295-5800
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
250000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
220000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13281000 usd
CY2023Q4 sdgr Allowance For Unbilled Receivables Current
AllowanceForUnbilledReceivablesCurrent
100000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
147322000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8718000 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
228263000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
65992000 usd
CY2024Q3 sdgr Allowance For Unbilled Receivables Current
AllowanceForUnbilledReceivablesCurrent
130000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
24922000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
23325000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11996000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
297000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
933424000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
885973000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-485325000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-338418000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
597000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
281000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
449425000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
548558000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
669296000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
802955000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35290000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42569000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
119222000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
222258000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-146458000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74431000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2887000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
449000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3041000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-38136000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-62024000 usd
us-gaap Net Income Loss
NetIncomeLoss
-146907000 usd
us-gaap Net Income Loss
NetIncomeLoss
71390000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1891000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-146591000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
73281000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
548558000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-353000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
390000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7615000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12218000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-54724000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
513706000 usd
CY2024Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-108000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
558000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1063000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12808000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-54047000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
473980000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
307688000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
4791000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
112816000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
117778000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5153000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6014000 usd
CY2024Q3 us-gaap Assets
Assets
669296000 usd
CY2023Q4 us-gaap Assets
Assets
802955000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11210000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16815000 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
33611000 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
31763000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41773000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
56231000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16887000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16868000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7636000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
111117000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
133673000 usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
5200000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9043000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
103257000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
111014000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
667000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
219871000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
254397000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142540000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
17562000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
18930000 usd
us-gaap Cost Of Revenue
CostOfRevenue
51269000 usd
us-gaap Cost Of Revenue
CostOfRevenue
59398000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
17728000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
23639000 usd
us-gaap Gross Profit
GrossProfit
67953000 usd
us-gaap Gross Profit
GrossProfit
83142000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50977000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46833000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
152423000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
130279000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10349000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9109000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30213000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27276000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24824000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23890000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73901000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73414000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
86150000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
79832000 usd
us-gaap Operating Expenses
OperatingExpenses
256537000 usd
us-gaap Operating Expenses
OperatingExpenses
230969000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-68422000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-56193000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-188584000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-147827000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2024Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
25459000 usd
CY2023Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-14522000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
27763000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
61869000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4737000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5804000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14363000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13067000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
30196000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
42126000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38226000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-64911000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-90000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72813006 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71924451 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72606033 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71679765 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.02
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72813006 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71924451 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-38136000 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
777000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
406000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12398000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-38136000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
449425000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
447894000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1483000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
867000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10880000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
129136000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
590260000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
216000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4698000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11773000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
4278000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
611225000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
192000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1534000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12654000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-62024000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
563581000 usd
us-gaap Net Income Loss
NetIncomeLoss
-146907000 usd
us-gaap Net Income Loss
NetIncomeLoss
71390000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
147322000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
27763000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
61869000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4395000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4198000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
37424000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
35307000 usd
sdgr Investment Amortization Noncash Expense
InvestmentAmortizationNoncashExpense
6260000 usd
sdgr Investment Amortization Noncash Expense
InvestmentAmortizationNoncashExpense
4962000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-140000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-52711000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-36069000 usd
sdgr Increase Decrease In Unbilled And Other Receivables
IncreaseDecreaseInUnbilledAndOtherReceivables
8418000 usd
sdgr Increase Decrease In Unbilled And Other Receivables
IncreaseDecreaseInUnbilledAndOtherReceivables
-884000 usd
sdgr Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets Operating
IncreaseDecreaseInReductionInTheCarryingAmountOfRightOfUseAssetsOperating
-7914000 usd
sdgr Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets Operating
IncreaseDecreaseInReductionInTheCarryingAmountOfRightOfUseAssetsOperating
-5722000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5314000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13048000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5442000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
742000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
729000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1848000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
626000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-18301000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-28114000 usd
sdgr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-7738000 usd
sdgr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2577000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-4412000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2607000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-126255000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-99478000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6438000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10924000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3000000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
4125000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
147136000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
48798000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
187466000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
224513000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
273467000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
345074000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
125361000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
252648000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1356000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7099000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
43000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
373000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8691000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10004000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6721000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
9110000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
159891000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161066000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95717000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170176000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
255608000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
847000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2194000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
30000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
274000 usd
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
138000 usd
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
685000 usd
sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets Contingency Resolution
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsContingencyResolution
2848000 usd
sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets Contingency Resolution
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsContingencyResolution
514000 usd
sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets In Exchange For Lease Obligations
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsInExchangeForLeaseObligations
0 usd
sdgr Noncash Or Part Noncash Acquisitions Of Right Of Use Assets In Exchange For Lease Obligations
NoncashOrPartNoncashAcquisitionsOfRightOfUseAssetsInExchangeForLeaseObligations
15085000 usd
CY2024Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
250000000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations<div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of trade receivables and contract assets, which represent contracted unbilled receivables.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not require customers to provide collateral to support accounts receivable. If deemed necessary, credit reviews of significant new customers may be performed prior to extending credit. The determination of a customer’s ability to pay requires judgment, and failure to collect from a customer can adversely affect revenue, cash flows, and results of operations.</span></div>
CY2024Q3 sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
3406000 usd
CY2023Q3 sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
13665000 usd
sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
18519000 usd
sdgr Revenue Recognized For Drug Discovery
RevenueRecognizedForDrugDiscovery
52071000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
30528000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
21107000 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
16959000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
45199000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
25439000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
55807000 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.89
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
39956000 usd
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
457027000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
548377000 usd
CY2024Q3 sdgr Finance And Operating Lease Weighted Average Remaining Lease Term
FinanceAndOperatingLeaseWeightedAverageRemainingLeaseTerm
P11Y
sdgr Increase In Right Of Use Assets Due To Contingency Resolution
IncreaseInRightOfUseAssetsDueToContingencyResolution
2952000 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
4527000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
4393000 usd
us-gaap Lease Cost
LeaseCost
13586000 usd
us-gaap Lease Cost
LeaseCost
12318000 usd
CY2024Q3 sdgr Operating And Finance Lease Payments
OperatingAndFinanceLeasePayments
5048000 usd
CY2023Q3 sdgr Operating And Finance Lease Payments
OperatingAndFinanceLeasePayments
3229000 usd
sdgr Operating And Finance Lease Payments
OperatingAndFinanceLeasePayments
13521000 usd
sdgr Operating And Finance Lease Payments
OperatingAndFinanceLeasePayments
8789000 usd
CY2024Q3 sdgr Lessee Operating And Finance Lease Liability To Be Paid Remainder Of Fiscal Year
LesseeOperatingAndFinanceLeaseLiabilityToBePaidRemainderOfFiscalYear
4259000 usd
CY2024Q3 sdgr Lessee Operating And Finance Lease Liability To Be Paid Year One
LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearOne
17579000 usd
CY2024Q3 sdgr Lessee Operating And Finance Lease Liability To Be Paid Year Two
LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo
17264000 usd
CY2024Q3 sdgr Lessee Operating And Finance Lease Liability To Be Paid Year Three
LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree
16080000 usd
CY2024Q3 sdgr Lessee Operating And Finance Lease Liability To Be Paid Year Four
LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour
14979000 usd
CY2024Q3 sdgr Lessee Operating And Finance Lease Liability To Be Paid After Year Four
LesseeOperatingAndFinanceLeaseLiabilityToBePaidAfterYearFour
112033000 usd
CY2024Q3 sdgr Lessee Operating And Finance Lease Liability To Be Paid
LesseeOperatingAndFinanceLeaseLiabilityToBePaid
182194000 usd
CY2024Q3 sdgr Lessee Operating And Finance Lease Liability Undiscounted Excess Amount
LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
61824000 usd
CY2024Q3 sdgr Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
120370000 usd
CY2024Q3 sdgr Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
17010000 usd
CY2024Q3 sdgr Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
103360000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-90000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
449000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2887000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3041000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3667000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12398000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12654000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37424000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35307000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.65
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.67
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M21D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y11M23D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0422
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0380
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-38136000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-62024000 usd
us-gaap Net Income Loss
NetIncomeLoss
-146907000 usd
us-gaap Net Income Loss
NetIncomeLoss
71390000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72813006 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71924451 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72606033 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71679765 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3287026 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72813006 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71924451 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72606033 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74966791 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35290000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42569000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
119222000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142540000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
17728000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
23639000 usd
us-gaap Gross Profit
GrossProfit
67953000 usd
us-gaap Gross Profit
GrossProfit
83142000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50977000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46833000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
152423000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
130279000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10349000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9109000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30213000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27276000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24824000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23890000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73901000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73414000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
147322000 usd
CY2024Q3 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
25459000 usd
CY2023Q3 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
-14522000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
27763000 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
61869000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4737000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5804000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14363000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13067000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-90000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2887000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
449000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3041000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-38136000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-62024000 usd
us-gaap Profit Loss
ProfitLoss
-146907000 usd
us-gaap Profit Loss
ProfitLoss
71390000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35290000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42569000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
119222000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142540000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001490978-24-000089-index-headers.html Edgar Link pending
0001490978-24-000089-index.html Edgar Link pending
0001490978-24-000089.txt Edgar Link pending
0001490978-24-000089-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sdgr-20240930.htm Edgar Link pending
sdgr-20240930.xsd Edgar Link pending
sdgr-20240930x10qex311.htm Edgar Link pending
sdgr-20240930x10qex312.htm Edgar Link pending
sdgr-20240930x10qex321.htm Edgar Link pending
sdgr-20240930x10qex322.htm Edgar Link pending
Show.js Edgar Link pending
sdgr-20240930_cal.xml Edgar Link unprocessable
sdgr-20240930_def.xml Edgar Link unprocessable
sdgr-20240930_htm.xml Edgar Link completed
sdgr-20240930_lab.xml Edgar Link unprocessable
sdgr-20240930_pre.xml Edgar Link unprocessable